Annual report pursuant to Section 13 and 15(d)

Revenue (Tables)

v3.7.0.1
Revenue (Tables)
12 Months Ended
Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Revenue from Product Sales

The Company has not generated revenue from product sales. The Company has generated revenue pursuant to (i) license and collaboration agreements, which include upfront payments for licenses or options to obtain licenses, payments for research and development services and milestone payments, and (ii) government grants.

 

     Years ended December 31,  
     2016      2015  

License fees

   $ 2,735,794      $ —  

Research and development services

     1,439,513        5,593  

Milestone payments

     1,655,367        2,538,698  

Government grants

     —          369,200  

Other Revenues

     —          18,440
  

 

 

    

 

 

 

Total Revenue

   $ 5,830,674      $ 2,931,931  
  

 

 

    

 

 

 
Balance Sheet Items Related to FP7 Agreement

The following balance sheet items relate to the FP7 agreement:

 

       Years Ended December 31,        
           2016                  2015        

Other current assets (receivables from FP7 grant)

   $ —        $ 980,936  

Cash (restricted cash)

   $ —        $ 17,302

Accounts payable

   $ —        $ 424,441